Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone

Jose C. Florez, Kathleen A. Jablonski, Maria W. Sun, Nick Bayley, Steven E. Kahn, Harry Shamoon, Richard F. Hamman, William C. Knowler, David M. Nathan, David Altshuler

Research output: Contribution to journalArticlepeer-review

114 Scopus citations

Fingerprint

Dive into the research topics of 'Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds